This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Recombinant immunotoxins development for HER2-based targeted cancer therapies
Cancer Cell International Open Access 06 September 2021
-
Selection of a novel DNA aptamer against OFA/iLRP for targeted delivery of doxorubicin to AML cells
Scientific Reports Open Access 14 May 2019
-
Role of Berberine in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections
Scientific Reports Open Access 22 April 2016
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Youlden DR, Cramb SM, Dunn NA, Muller JM, Pyke CM, Baade PD . The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol 2012; 36: 237–248.
Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ et al. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 2011; 22: 1736–1747.
Cooke T, Reeves J, Lanigan A, Stanton P . HER2 as a prognostic and predictive marker for breast cancer. Ann Oncol 2001; 12: S23–S28.
Holbro T, Civenni G, Hynes NE . The ErbB receptors and their role in cancer progression. Exp Cell Res 2003; 284: 99–110.
Hoang MP, Sahin AA, Ordonez NG, Sneige N . HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma. Am J Clin Pathol 2000; 113: 852–859.
Lebeau A, Deimling D, Kaltz C, Sendelhofert A, Iff A, Luthardt B et al. Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization. J Clin Oncol 2001; 19: 354–363.
Tuerk C, Gold L . Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990; 249: 505–510.
Konry T, Hayman RB, Walt DR . Microspherebased rolling circle amplification microarray for the detection of DNA and proteins in a single assay. Anal Chem 2009; 81: 5777–5782.
Liu Z, Duan JH, Song YM, Ma J, Wang FD, Lu X et al. Novel HER2 aptamer selectively delivers cytotoxic drug to HER2-positive breast cancer cells in vitro. J Transl Med 2012; 10: 148.
Baner J, Nilsson M, Mendel-Hartvig M, Landegren U . Signal amplification of padlock probes by rolling circle replication. Nucleic Acids Res 1998; 26: 5073–5078.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chu, M., Kang, Jr., Wang, W. et al. Evaluation of human epidermal growth factor receptor 2 in breast cancer with a novel specific aptamer. Cell Mol Immunol 14, 398–400 (2017). https://doi.org/10.1038/cmi.2015.31
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cmi.2015.31
This article is cited by
-
Recombinant immunotoxins development for HER2-based targeted cancer therapies
Cancer Cell International (2021)
-
Selection of a novel DNA aptamer against OFA/iLRP for targeted delivery of doxorubicin to AML cells
Scientific Reports (2019)
-
Role of Berberine in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections
Scientific Reports (2016)